Endothelial progenitor cells may participate in stress-induced tumour angiogenesis

Medical Hypotheses

Volumn 80, Issue 6, 2013, Pages 778-780

  Jiang, Qijun ^a   Gong, Zhigang ^a   Ding, Shifang ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEUROTRANSMITTER; PROTEIN KINASE;

ANGIOGENESIS; ARTICLE; CHRONIC STRESS; ENDOTHELIAL PROGENITOR CELL; HUMAN; TUMOR ANGIOGENESIS; UPREGULATION;

ENDOTHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION; STEM CELLS; STRESS, PHYSIOLOGICAL;

ANIMALIA;

EID: 84877132437     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.03.010     Document Type: Article

References (24)

1. Anand P., Kunnumakkara A., Sundaram C., Harikumar K., Tharakan S., Lai O., et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008, 25:2097-2116.
2. Lillberg K., Verkasalo P., Kaprio J., Teppo L., Helenius H., Koskenvuo M. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol 2003, 157:415-423.
3. Lutgendorf S., Sood A., Anderson B., McGinn S., Maiseri H., Dao M., et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol 2005, 23:7105-7113.
4. Thaker P., Han L., Kamat A., Arevalo J., Takahashi R., Lu C., et al. Chronic stress promotes tumour growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006, 12:939-944.
5. Moreno-Smith M., Lu C., Shahzad M., Pena G., Allen J., Stone R., et al. Dopamine blocks stress-mediated ovarian carcinoma growth. Clin Cancer Res 2011, 17:3649-3659.
6. Barbieri A., Palma G., Rosati A., Giudice A., Falco A., Petrillo A., et al. Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth. J Cell Mol Med 2012, 16:920-926.
7. Nausheen B., Carr N.J., Peveler R.C., Moss-Morris R., Verrill C., Robbins E., et al. Relationship between loneliness and proangiogenic cytokines in newly diagnosed tumours of colon and rectum. Psychosom Med 2010, 72:912-916.
8. Sharma A., Greenman J., Sharp D.M., Walker L.G., Monson J.R. Vascular endothelial growth factor and psychosocial factors in colorectal cancer. Psychooncology 2008, 17:66-73.
9. Lutgendorf S.K., Johnsen E.L., Cooper B., Anderson B., Sorosky J.I., Buller R.E., et al. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 2002, 95:808-815.
10. Lutgendorf S.K., Lamkin D.M., Jennings N.B., Arevalo J.M., Penedo F., DeGeest K., et al. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma. Clin Cancer Res 2008, 14:6839-6846.
11. Wong H., Yu L., Lam E., Tai E., Wu W., Cho C. Nicotine promotes colon tumour growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 2007, 97:279-287.
12. Lamy S., Lachambre M., Lord-Dufour S., Beliveau R. Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells. Vascul Pharmacol 2010, 53:200-208.
13. Yang E.V., Sood A.K., Chen M., Li Y., Eubank T.D., Marsh C.B., et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumour cells. Cancer Res 2006, 66:10357-10364.
14. Garcia-Barros M., Paris F., Cordon-Cardo C., Lyden D., Rafii S., Haimovitz-Friedman A., et al. Tumour response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
15. Goon P., Lip G., Boos C., Stonelake P., Blann A. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 2006, 8:79-88.
16. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumour angiogenesis and growth. Nat Med 2001, 7:1194-1201.
17. Dome B., Dobos J., Tovari J., Paku S., Kovacs G., Ostoros G., et al. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 2008, 73:186-193.
18. Su Y., Zheng L., Wang Q., Li W., Cai Z., Xiong S., et al. Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer. J Exp Clin Cancer Res 2010, 29:27.
19. Tabarowski Z., Gibson-Berry K., Felten S. Noradrenergic and peptidergic innervation of the mouse femur bone marrow. Acta Histochem 1996, 98:453-457.
20. Dygai A., Skurikhin E. Monoaminergic regulation of hemopoiesis under extreme conditions. Bull Exp Biol Med 2011, 151:171-178.
21. Muthu K., Iyer S., He L., Szilagyi A., Gamelli R., Shankar R., et al. Murine hematopoietic stem cells and progenitors express adrenergic receptors. J Neuroimmunol 2007, 186:27-36.
22. Kubota Y. Tumour angiogenesis and anti-angiogenic therapy. Keio J Med 2012, 61:47-56.
23. Ueda Y., Yamagishi T., Ikeya H., Hirayama N., Itokawa T., Aozuka Y., et al. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo. Anticancer Res 2004, 24:3009-3017.
24. Fidler I.J., Ellis L.M. Neoplastic angiogenesis. N Engl J Med 2004, 351:215-216.